Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study. (Record no. 29343352)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01948 a2200529 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518022537.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201912s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1524-4741 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1111/tbj.13199 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Manso, Luis |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20191202 |
| 245 00 - TITLE STATEMENT | |
| Title | Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The breast journal |
| Date of publication, distribution, etc. | 03 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 219-225 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anthracyclines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Furans |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ketones |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplastic Cells, Circulating |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptor, ErbB-2 |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Taxoids |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moreno Antón, Fernando |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Izarzugaza Perón, Yann |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Delgado Mingorance, Juan I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Borrega García, Pablo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Echarri González, María J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martínez-Jañez, Noelia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | López-González, Ana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Olier Garate, Clara |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ballesteros García, Anabel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chacón López-Muñíz, Ignacio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ciruelos Gil, Eva |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | García-Sáenz, Jose Angel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Paz-Ares, Luis |
| 773 0# - HOST ITEM ENTRY | |
| Title | The breast journal |
| Related parts | vol. 25 |
| -- | no. 2 |
| -- | p. 219-225 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1111/tbj.13199">https://doi.org/10.1111/tbj.13199</a> |
| Public note | Available from publisher's website |
No items available.